Microsatellite instability in colorectal cancer

Weitz J, Koch M, Debus J, Höhler T, Galle PR, Büchler MW. Colorectal cancer. Lancet 2005; 365: 153-65.10.1016/S0140-6736(05)17706-XSearch in Google Scholar

Primic-Žakelj M, Zadnik V, Žagar T, Zakotnik B. Survival of cancer patients, diagnosed in 1991-2005 in Slovenia. Ljubljana: Institute of Oncology Ljubljana, Cancer Registry of Republic of Slovenia; 2009.Search in Google Scholar

Cancer incidence in Slovenia 2007. Ljubljana: Institute of Oncology Ljubljana, Cancer Registry of Republic of Slovenia; 2010.Search in Google Scholar

Velenik V. Post-treatment surveillance in colorectal cancer. Radiol Oncol 2010; 44: 135-41.10.2478/v10019-010-0018-8Search in Google Scholar

Zhou YL, Boardman LA, Miller RC. Genetic testing for young-onset colorectal cancer: case report and evidence-based clinical guidelines. Radiol Oncol 2010; 44: 57-61.10.2478/v10019-010-0005-0Search in Google Scholar

Fearon ER, Vogelstein B. A genetic model for colorectal tumourogenesis. Cell 1990; 61: 759-67.10.1016/0092-8674(90)90186-ISearch in Google Scholar

West NJ, Courtney EDY, Poullis AP, Leicester RJ. Apoptosis in the colonic crypt, colorectal adenomata, and manipulation by chemoprevention. Cancer Epidemiol Biomarkers Prev 2009; 18: 1680-7.10.1158/1055-9965.EPI-09-0006Search in Google Scholar

Duval A, Hamelin R. Mutations at coding repeat sequences in mismatch repair-deficient human cancers: toward a new concept of target genes for instability. Cancer Res 2002; 62: 2447-54.Search in Google Scholar

Lynch JP, Hoops TC. The genetic pathogenesis of colorectal cancer. Hemat Oncol Clin N Am 2002; 16: 775-810.10.1016/S0889-8588(02)00029-1Search in Google Scholar

Kondo Y, Issa JPJ. Epigenetic changes in colorectal cancer. Cancer Met Rev 2004; 23: 29-39.10.1023/A:1025806911782Search in Google Scholar

Kozuka S, Nogaki M, Ozeki T, Masumori S. Premalignancy of the mucosal polyp in the large intestine. Estimation of the periods required for malignant transformation of mucosal polyps. Dis Colon Rectum 1975; 18: 494-500.10.1007/BF025872181181151Search in Google Scholar

Kinzler K, Vogelstein B. Gatekeepers and caretakers. Nature 1997; 386: 761-3.10.1038/386761a09126728Search in Google Scholar

Grady WM. Genomic instability and colon cancer. Cancer Metast Rev 2004; 23: 11-27.10.1023/A:1025861527711Search in Google Scholar

Stoler DL, Chen N, Basik M, Kahlenberg MS, Rodriguez-Bigas MA, Petrelli NJ, et al. The onset and extent of genomic instability in sporadic colorectal tumour progression. Proc Natl Acad Sci USA 1999; 96: 15121-6.10.1073/pnas.96.26.15121Search in Google Scholar

Law DJ, Olschwang S, Monpezat J-P. Concerted nonsystemic allelic loss in human colorectal carcinoma. Science 1988; 241: 961-5.10.1126/science.2841761Search in Google Scholar

Paulovich AG, Toczyski DP, Hartwell LH. When checkpoints fail. Cell 1997; 88: 315-21.10.1016/S0092-8674(00)81870-XSearch in Google Scholar

Vogelstein B, Fearon ER, Hamilton SR, Kern SE, Preisinger AC, Leppert M, et al. Genetic alterations during colorectal tumour development. N Engl J Med 1988; 319: 525-32.10.1056/NEJM1988090131909012841597Search in Google Scholar

Powell SM, Zilz N, Beazer-Barclay Y. APC mutations occur early during colorectal oncogenesis. Nature 1992; 359: 235-7.10.1038/359235a01528264Search in Google Scholar

Lenglauer C, Kinzler KW, Vogelstein B. Genetic instability in colorectal cancers. Nature 1997; 386: 623-7.10.1038/386623a09121588Search in Google Scholar

Jass JR, Whitehall VLJ, Young J, Leggett BA. Emerging concepts in colorectal neoplasia. Gastroenterology 2002; 123: 862-76.10.1053/gast.2002.3539212198712Search in Google Scholar

Thibodeau SN, Bren G, Schaid D. Microsatellite instability in cancer of the proximal colon. Science 1993; 260: 816-9.10.1126/science.84841228484122Search in Google Scholar

Worthley DL, Leggett BA. Colorectal cancer: Molecular features and clinical opportunities. Clin Biochem Rev 2010; 31: 31-8.Search in Google Scholar

De la Chapelle A, Hampel H. Clinical relevance of microsatellite instability in colorectal cancer. J Clin Oncol 2010; 28: 3380-7.10.1200/JCO.2009.27.0652290333120516444Search in Google Scholar

Radman M, Wagner R. Carcinogenesis. Missing mismatch repair. Nature 1993; 366: 722.10.1038/366722a08264794Search in Google Scholar

McClulloch SD, Kunkel TA. The fidelity of DNA synthesis by eukaryotic replicative and translesion synthesis polymerases. Cell Res 2008; 18: 148-61.10.1038/cr.2008.4Search in Google Scholar

Eshleman JR, Markowitz SD. Mismatch repair defects in human carcinogenesis. Hum Mol Genet 1996; 5: 1489-94.10.1093/hmg/5.Supplement_1.1489Search in Google Scholar

Umar A, Boland CR, Terdiman JP. Revised Bethesda guidelines for hereditary non-poliposis colorectal cancer (Lynch syndrome) and microsatellite instability. J Natl Cancer Inst 2004; 96: 261-8.10.1093/jnci/djh034Search in Google Scholar

Jover R, Zapater P, Castells A, Llor X, Andreu M, Cubiella J, et al. Mismatch repair status in the prediction of benefit from adjuvant Flourouracil chemotherapy in colorectal cancer. Gut 2006; 55: 848-55.10.1136/gut.2005.073015Search in Google Scholar

Niv Y. Microsatellite instability and MLH1 promoter hypermetalition in colorectal cancer. World J Gastroenterol 2007; 13: 1767-9.10.3748/wjg.v13.i12.1767Search in Google Scholar

Liang JT, Huang KC, Lai HS, Lee PH, Cheng YM, Hsu HC, et al. High frequency microsatellite instability predicts better chemosensitivity to high dose 5-fluorouracil plus Leucovorin chemotherapy for stage IV sporadic colorectal cancer after palliative bowel resection. Int J Cancer 2002; 101: 519-25.10.1002/ijc.10643Search in Google Scholar

Markowitz S, Wang J Myeroff L, Parsons R, Sun L, Lutterbaugh J, et al. Inactivation of the type II TGF-beta receptor in colon cancer cells with microsatellite instability. Science 1995; 268: 1336-8.10.1126/science.7761852Search in Google Scholar

Lawes DA, SenGupta S, Boulos PB. The clinical importance and prognostic implications of microsatellite instability in sporadic cancer. Eur J Surg Oncol 2003; 29: 201-12.10.1053/ejso.2002.1399Search in Google Scholar

Modrich P. Mechanisms and biological effects of mismatch repair. Ann Rev Genet 1991; 25: 229-53.10.1146/annurev.ge.25.120191.001305Search in Google Scholar

Joseph N, Duppatla V, Rao DN. Prokaryotic DNA mismatch repair. Prog Nucleic Acid Res 2006; 81: 1-49.10.1016/S0079-6603(06)81001-9Search in Google Scholar

Iyer R, Pluciennik A, Modrich P, Modrich PL. DNA mismatch repair: functions and mechanisms. Chem Rev 2006; 106: 302-23.10.1021/cr040479416464007Search in Google Scholar

Hsieh P, Yamane K. DNA mismatch repair: Molecular mechanisms, cancer and ageing. Mech Ageing Dev 2008; 129: 391-407.10.1016/j.mad.2008.02.012257495518406444Search in Google Scholar

Shibata D, Peinado MA, Ionov Y, Malkhosyan S, Perucho M. Genomic instability in repeated sequences is an early somatic event in colorectal tumorogenesis that persists after transformation. Nat Genet 1994; 6: 273-81.10.1038/ng0394-2738012390Search in Google Scholar

Warusavitarne J, Schnitzler M. The role of chemotherapy in microsatellite unstable (MSI-H) colorectal cancer. Int J Colorectal Dis 2007; 22: 739-48.10.1007/s00384-006-0228-017109103Search in Google Scholar

Aaltonen LA, Peltomaki P, Leach FS, Sistonen P, Pylkkänen L, Mecklin JP, et al. Clues to the pathogenesis of familial colorectal cancer. Science 1993; 260: 812-6.10.1126/science.84841218484121Search in Google Scholar

Gryfe R, Kim H, Hsieh ETK, Aronson MD, Holowaty EJ, Bull SB et al. Tumor microsatellite instability and clinical outcome in young patients with colorectal cancer. N Engl J Med 2000; 342: 69-77.10.1056/NEJM20000113342020110631274Search in Google Scholar

Hemminki A, Mecklin JP, Jarvinen H, Aaltonen LA, Joensuu H. Microsatellite instability is a favorable prognostic indicator in patients with colorectal cancer receiving chemotherapy. Gastroenterology 2000; 119: 921-8.10.1053/gast.2000.1816111040179Search in Google Scholar

Popat S, Hubner R, Houlston RS. Systematic review of microsatellite instability and colorectal cancer prognosis. J Clin Oncol 2005; 23: 609-18.10.1200/JCO.2005.01.08615659508Search in Google Scholar

Lim SB, Jeong SY, Lee MR, Ku JL, Shin YK, Kim WH, et al. Prognostic signifance of microsatellite instability in sporadic colorectal cancer. Int J Colorectal Dis 2004; 19: 533-7.10.1007/s00384-004-0596-215175889Search in Google Scholar

Fink D, Nebel S, Aebi S, Zheng H, Cenni B, Nehmé A, et al. The role of DNA mismatch repair in platinum drug resistance. Cancer Res 1996; 56: 4881-6.Search in Google Scholar

Vaisman A, Varchenko M, Umar A, Kunkel TA, Risinger JI, Barrett JC, et al. The role of hMLH1, hMSH3 and hMSH6 defects in Cisplatin and Oxaliplatin resistance: correlation with replicative bypass of platinum-DNA adducts. Cancer Res 1998; 58: 3579-85.Search in Google Scholar

Bras-Goncalves RA, Rosty C, Laurent-Puig P, Soulié P, Dutrillaux B, Poupon MF. Sensitivity to CPT-11 of xenografted human colorectal cancers as a function of microsatellite instability and p53 status. Br J Cancer 2000; 82: 913-23.10.1054/bjoc.1999.1019237441210732766Search in Google Scholar

Aebi S, Kurdi-Haidar B, Gordon R, Cenni B, Zheng H, Fink D, et al. Loss of DNA mismatch repair in acquired resistance to Cisplatin. Cancer Res 1996; 56: 3087-90.Search in Google Scholar

Fallik D, Borrini F, Boige V, Viguier J, Jacob S, Miquel C, et al. Microsatellite instability is a predictive factor of the tumor response to Irinotecan in patients with advanced colorectal cancer. Cancer Res 2003; 63: 5738-44.Search in Google Scholar

Rothenberg ML, Meropol NJ, Poplin EA, Van Cutsem E, Wadler S. Mortality associated with Irinotecan plus bolus Flourouracil/Leucovorin. Summary findings of an independent panel. J Clin Oncol 2001; 19: 3801-7.10.1200/JCO.2001.19.18.3801Search in Google Scholar

Braun MS, Richman SD, Thompson L, Daly CL, Meade AM, Adlard JW, et al. Association of molecular markers with toxicity outcomes in a randomized trial of chemotherapy for advanced colorectal cancer: The FOCUS trial. J Clin Oncol 2009; 27: 5519-28.10.1200/JCO.2008.21.6283Search in Google Scholar

Ocvirk J. Advances in the treatment of metastatic colorectal carcinoma. Radiol Oncol 2009; 43: 1-8.10.2478/v10019-009-0004-1Search in Google Scholar

Adlard JW, Richman SD, Seymour MT, Quirke P. Prediction of the response of colorectal cancer to systemic therapy. Lancet Oncol 2002; 8: 75-82.10.1016/S1470-2045(02)00648-4Search in Google Scholar

Fischer F, Baerenfaller K, Jiricny J. 5-flourouracil is efficiently removed from DNA by the base excision and mismatch repair systems. Gastroenterology 2007; 133: 1858-68.10.1053/j.gastro.2007.09.003Search in Google Scholar

Ricciardiello L, Ceccarelli C, Angiolini G, Pariali M, Chieco P, Paterini P, et al. High tymidylate synthase expression in colorectal cancer with microsatellite instability: implications for chemotherapeutic strategies. Clin Cancer Res 2005; 11: 4234-40.10.1158/1078-0432.CCR-05-0141Search in Google Scholar

Tajima A, Hess MT, Cabrera BL, Kolodner RD, Carethers JM. The mismatch repair complex hMutS alpha recognizes 5-flourouracil modified DNA: implications for chemosensitivity and resistance. Gastroenterology 2004; 127: 1678-84.10.1053/j.gastro.2004.10.001Search in Google Scholar

Carethers JM, Chauhan DP, Fink D, Nebel S, Bresalier RS, Howell SB, et al. Mismatch repair proficiency and in vitro response to 5-flourouracil. Gastroenterology 1999; 117: 123-31.10.1016/S0016-5085(99)70558-5Search in Google Scholar

Kirchner T, Jung A. Pathologische Diagnostik fuer die individualisierte Therapie des Dickdarmkarzinoms. Pathologe 2010; 31: 16-21.10.1007/s00292-009-1240-219957085Search in Google Scholar

Jover R, Zapater P, Castells A, Llor X, Andreu M, Cubiella J, et al. The efficacy of adjuvant chemotherapy with 5-flourouracil in colorectal cancer depends on the mismatch repair status. Eur J Cancer 2009; 45: 365-73.10.1016/j.ejca.2008.07.01618722765Search in Google Scholar

Ribic CM, Sargent DJ, Moore MJ, Thibodeau SN, French AJ, Goldberg RM, et al. Tumor microsatellite-instability status as a predictor of benefit from Flourouracil-based adjuvant chemotherapy for colon cancer. N Eng J Med 2003; 349: 247-57.10.1056/NEJMoa022289358463912867608Search in Google Scholar

Magrini R, Bhonde MR, Hanski M, Notter M, Scherübl H, Boland CR. Cellular effects of CPT-11 on colon carcinoma cells: dependence on p53 and hMLH1 status. Int J Cancer 2002; 101: 23-31.10.1002/ijc.1056512209584Search in Google Scholar

Chamara M, Edmonston TB, Burkholder S, Walters R, Anne P, Mitchell E, et al. Microsatellite status and cell cycle associated markers in rectal cancer patients undergoing combined regimen of 5-FU and CPT-11 chemotherapy and radiotherapy. Anticancer Res 2004; 24: 3161-7.Search in Google Scholar

Fink D, Aebi S, Howell SB. The role of DNA mismatch repair in drug resistance. Cancer Res 1998; 4: 1-6.Search in Google Scholar

Claij N, te Riele H. Microsatellite instability in human cancer: a prognostic marker for chemotherapy? Exp Cell Res 1999; 246: 1-10.10.1006/excr.1998.42999882509Search in Google Scholar

Des Guetz G, Schischmanoff O, Nicolas P, Perret GY, Morere JF, Uzzan B. Does microsatellite instability predict the efficacy of adjuvant chemotherapy in colorectal cancer? A systematic review with meta-analysis. Eur J Cancer 2009; 45: 1890-6.10.1016/j.ejca.2009.04.01819427194Search in Google Scholar

Des Guetz G, Uzzan B, Nicolas P, Schischmanoff O, Perret GY, Morere JF. Microsatellite instability does not predict the efficacy of chemotherapy in metastatic colorectal cancer. A systematic review and meta-analysis. Anticancer Res 2009; 29: 1615-20.Search in Google Scholar

Des Guetz G, Mariani P, Cucherousset J, Benamoun M, Lagorce C, Sastre X et al. Microsatellite instability and sensitivity to FOLFOX treatment in metastatic colorectal cancer. Anticancer Res 2007; 27: 2715-19.Search in Google Scholar

Guastadisegni C, Colafranceschi M, Ottini L, Dogliotti E. Microsatellite instability as a marker of prognosis and response to therapy. A meta analysis of colorectal cancer survival data. Eur J Cancer 2010; 46: 2788-98.10.1016/j.ejca.2010.05.00920627535Search in Google Scholar

Sinicrope F, Foster NR, Sargent DJ, Thibodeau SN, Smyrk TC, O'Connell MJ et al. Model-based prediction of defective DNA mismatch repair using clinicopathological variables in sporadic colon cancer patients. Cancer 2010; 116: 1691-8.10.1002/cncr.24913285530020186699Search in Google Scholar